SCHEMBL8976746

SCHEMBL8976746

C/C(=C\c1cccc2ccccc12)CN1CCN(Cc2ccccc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
LMNA P02545 3/20 0.47
USP2 O75604 2/20 0.47
ALOX15 P16050 2/20 0.47
MAPK1 P28482 2/20 0.47
KDM4E B2RXH2 1/20 0.47
HSD17B10 Q99714 1/20 0.47
SIGMAR1 Q99720 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
TSHR P16473 1/20 0.45
MC4R P32245 1/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
MAPT P10636 1/20 0.43
NPFFR1 Q9GZQ6 3/20 0.43
NPFFR2 Q9Y5X5 3/20 0.43
POLB P06746 1/20 0.43
DRD4 P21917 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8976751 1.00 ALDH1A1 (0.47) ALDH1A1LMNAUSP2ALOX15MAPK1
SCHEMBL8976956 0.81 ALDH1A1 (0.55) ALDH1A1LMNAUSP2ALOX15MAPK1
SCHEMBL8976961 0.81 ALDH1A1 (0.55) ALDH1A1LMNAUSP2ALOX15MAPK1
SCHEMBL8976340 0.79 SMN1; SMN2 (0.68) ALDH1A1LMNAUSP2ALOX15MAPK1
SCHEMBL8976337 0.79 SMN1; SMN2 (0.68) ALDH1A1LMNAUSP2ALOX15MAPK1
SCHEMBL8976331 0.72 SMN1; SMN2 (0.62) ALDH1A1LMNAUSP2ALOX15MAPK1
SCHEMBL8976338 0.72 SMN1; SMN2 (0.62) ALDH1A1LMNAUSP2ALOX15MAPK1
SCHEMBL8976310 0.72 SMN1; SMN2 (0.62) ALDH1A1LMNAUSP2ALOX15MAPK1
SCHEMBL8976303 0.72 SMN1; SMN2 (0.62) ALDH1A1LMNAUSP2ALOX15MAPK1
SCHEMBL8976618 0.72 SIGMAR1 (0.64) ALDH1A1LMNAUSP2ALOX15KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0707004-A1 1-Arylalcenyl 4-arylmethylpiperazinderivatives, process for their preparation and pharmaceutical composition containing them ADIR ET COMPAGNIE (FR) 1996-04-17 EP disclosed